Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report)’s share price traded up 14.3% during mid-day trading on Thursday . The stock traded as high as $0.32 and last traded at $0.32. 86,573 shares were traded during mid-day trading, an increase of 1,568% from the average session volume of 5,191 shares. The stock had previously closed at $0.28.
Guided Therapeutics Stock Performance
The business’s 50-day moving average is $0.23 and its 200-day moving average is $0.29. The company has a market capitalization of $30.89 million, a PE ratio of -8.00 and a beta of 0.72.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.01) earnings per share for the quarter.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non?invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.
The company secured 510(k) clearance from the U.S.
Featured Articles
- Five stocks we like better than Guided Therapeutics
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
